| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Jefferies reiterates Buy on BioAge Labs stock citing NLRP3 progress | ||
| Di | BTIG reiterates Buy on Rezolute stock, keeps $5 target after FDA update | ||
| Di | Freedom Capital Markets upgrades Canadian Solar stock rating to buy | ||
| Di | BofA reiterates Freshpet stock rating amid new competition | ||
| Di | Velo3D reports 2025 results, projects revenue up to $70 million | ||
| Di | Reed's appoints interim CEO as Q4 sales decline to $7.5 million | ||
| Di | Comstock adds three independent directors in board overhaul | ||
| Di | Twin Vee PowerCats closes $2.5M stock offering | ||
| Di | Leonardo DRS launches rugged computing system for military vehicles | ||
| Di | Empery Digital closes $25M equity raise above net asset value | ||
| Di | CollPlant receives Nasdaq bid price deficiency notice | ||
| Di | BofA cuts Hesai Group stock price target on higher costs | ||
| Di | Why is CoreWeave Inc up today? | ||
| Di | Morgan Stanley reiterates Alnylam stock Equalweight rating at $360 | ||
| Di | RBC Capital reiterates Core & Main stock rating on execution | ||
| Di | Alnylam stock price target maintained at $460 by BofA Securities | ||
| Di | Guggenheim reiterates Dollar General stock rating on CEO succession | ||
| Di | Oppenheimer reiterates Outperform on BioAge Labs stock at $60 | ||
| Di | Mizuho raises Enliven Therapeutics price target to $45 on CML data | ||
| Di | Needham reiterates Vertical Aerospace stock rating on flight milestone | ||
| Di | Clear Street reiterates Cullinan Oncology stock rating on Gilead deal validation | ||
| Di | Raymond James says helium concerns behind Radnet stock sell-off overblown | ||
| Di | Mizuho reiterates Fate Therapeutics stock rating on trial progress | ||
| Di | Public Health group sues DraftKings, FanDuel, NFL over betting addiction | ||
| Di | BofA cuts Progressive stock price target on lower market multiples |